Global Oncology Precision Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Oncology Precision Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Oncology Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Precision Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oncology Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oncology Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oncology Precision Medicine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Precision Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Precision Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc and Asuragen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oncology Precision Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Oncology Precision Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Precision Medicine, with revenue, gross margin and global market share of Oncology Precision Medicine from 2018 to 2023.
Chapter 3, the Oncology Precision Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncology Precision Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Precision Medicine.
Chapter 13, to describe Oncology Precision Medicine research findings and conclusion.
This report is a detailed and comprehensive analysis for global Oncology Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Precision Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oncology Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oncology Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oncology Precision Medicine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Precision Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Precision Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc and Asuragen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oncology Precision Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Applied Sciences
- Precision Diagnostics
- Digital Health and Information Technology
- Precision Therapeutics
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Other Cancer
- Abbott Laboratories
- Agilent Technologies
- Almac
- ANGLE plc
- Asuragen
- BGI Group
- Bio-Rad Laboratories
- BioM?rieux
- Bristol Myers Squibb
- Roche Holding AG
- Gilead Sciences
- Illumina
- Konica Minolta
- LabCorp
- MDxHealth
- Myriad Genetics
- Novartis
- OPKO Health
- Pacific Biosciences
- Quest Diagnostics
- Qiagen
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Oncology Precision Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Precision Medicine, with revenue, gross margin and global market share of Oncology Precision Medicine from 2018 to 2023.
Chapter 3, the Oncology Precision Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncology Precision Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Precision Medicine.
Chapter 13, to describe Oncology Precision Medicine research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology Precision Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Precision Medicine by Type
1.3.1 Overview: Global Oncology Precision Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oncology Precision Medicine Consumption Value Market Share by Type in 2022
1.3.3 Applied Sciences
1.3.4 Precision Diagnostics
1.3.5 Digital Health and Information Technology
1.3.6 Precision Therapeutics
1.4 Global Oncology Precision Medicine Market by Application
1.4.1 Overview: Global Oncology Precision Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Lung Cancer
1.4.4 Colorectal Cancer
1.4.5 Prostate Cancer
1.4.6 Cervical Cancer
1.4.7 Other Cancer
1.5 Global Oncology Precision Medicine Market Size & Forecast
1.6 Global Oncology Precision Medicine Market Size and Forecast by Region
1.6.1 Global Oncology Precision Medicine Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oncology Precision Medicine Market Size by Region, (2018-2029)
1.6.3 North America Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.4 Europe Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.6 South America Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oncology Precision Medicine Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Precision Medicine Product and Solutions
2.1.4 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Oncology Precision Medicine Product and Solutions
2.2.4 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Almac
2.3.1 Almac Details
2.3.2 Almac Major Business
2.3.3 Almac Oncology Precision Medicine Product and Solutions
2.3.4 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Almac Recent Developments and Future Plans
2.4 ANGLE plc
2.4.1 ANGLE plc Details
2.4.2 ANGLE plc Major Business
2.4.3 ANGLE plc Oncology Precision Medicine Product and Solutions
2.4.4 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 ANGLE plc Recent Developments and Future Plans
2.5 Asuragen
2.5.1 Asuragen Details
2.5.2 Asuragen Major Business
2.5.3 Asuragen Oncology Precision Medicine Product and Solutions
2.5.4 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Asuragen Recent Developments and Future Plans
2.6 BGI Group
2.6.1 BGI Group Details
2.6.2 BGI Group Major Business
2.6.3 BGI Group Oncology Precision Medicine Product and Solutions
2.6.4 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BGI Group Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
2.7.4 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 BioM?rieux
2.8.1 BioM?rieux Details
2.8.2 BioM?rieux Major Business
2.8.3 BioM?rieux Oncology Precision Medicine Product and Solutions
2.8.4 BioM?rieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BioM?rieux Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
2.9.4 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Roche Holding AG
2.10.1 Roche Holding AG Details
2.10.2 Roche Holding AG Major Business
2.10.3 Roche Holding AG Oncology Precision Medicine Product and Solutions
2.10.4 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Roche Holding AG Recent Developments and Future Plans
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Oncology Precision Medicine Product and Solutions
2.11.4 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Gilead Sciences Recent Developments and Future Plans
2.12 Illumina
2.12.1 Illumina Details
2.12.2 Illumina Major Business
2.12.3 Illumina Oncology Precision Medicine Product and Solutions
2.12.4 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Illumina Recent Developments and Future Plans
2.13 Konica Minolta
2.13.1 Konica Minolta Details
2.13.2 Konica Minolta Major Business
2.13.3 Konica Minolta Oncology Precision Medicine Product and Solutions
2.13.4 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Konica Minolta Recent Developments and Future Plans
2.14 LabCorp
2.14.1 LabCorp Details
2.14.2 LabCorp Major Business
2.14.3 LabCorp Oncology Precision Medicine Product and Solutions
2.14.4 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 LabCorp Recent Developments and Future Plans
2.15 MDxHealth
2.15.1 MDxHealth Details
2.15.2 MDxHealth Major Business
2.15.3 MDxHealth Oncology Precision Medicine Product and Solutions
2.15.4 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 MDxHealth Recent Developments and Future Plans
2.16 Myriad Genetics
2.16.1 Myriad Genetics Details
2.16.2 Myriad Genetics Major Business
2.16.3 Myriad Genetics Oncology Precision Medicine Product and Solutions
2.16.4 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Myriad Genetics Recent Developments and Future Plans
2.17 Novartis
2.17.1 Novartis Details
2.17.2 Novartis Major Business
2.17.3 Novartis Oncology Precision Medicine Product and Solutions
2.17.4 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Novartis Recent Developments and Future Plans
2.18 OPKO Health
2.18.1 OPKO Health Details
2.18.2 OPKO Health Major Business
2.18.3 OPKO Health Oncology Precision Medicine Product and Solutions
2.18.4 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 OPKO Health Recent Developments and Future Plans
2.19 Pacific Biosciences
2.19.1 Pacific Biosciences Details
2.19.2 Pacific Biosciences Major Business
2.19.3 Pacific Biosciences Oncology Precision Medicine Product and Solutions
2.19.4 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Pacific Biosciences Recent Developments and Future Plans
2.20 Quest Diagnostics
2.20.1 Quest Diagnostics Details
2.20.2 Quest Diagnostics Major Business
2.20.3 Quest Diagnostics Oncology Precision Medicine Product and Solutions
2.20.4 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Quest Diagnostics Recent Developments and Future Plans
2.21 Qiagen
2.21.1 Qiagen Details
2.21.2 Qiagen Major Business
2.21.3 Qiagen Oncology Precision Medicine Product and Solutions
2.21.4 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Qiagen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncology Precision Medicine Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oncology Precision Medicine by Company Revenue
3.2.2 Top 3 Oncology Precision Medicine Players Market Share in 2022
3.2.3 Top 6 Oncology Precision Medicine Players Market Share in 2022
3.3 Oncology Precision Medicine Market: Overall Company Footprint Analysis
3.3.1 Oncology Precision Medicine Market: Region Footprint
3.3.2 Oncology Precision Medicine Market: Company Product Type Footprint
3.3.3 Oncology Precision Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncology Precision Medicine Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oncology Precision Medicine Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncology Precision Medicine Consumption Value Market Share by Application (2018-2023)
5.2 Global Oncology Precision Medicine Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Oncology Precision Medicine Consumption Value by Type (2018-2029)
6.2 North America Oncology Precision Medicine Consumption Value by Application (2018-2029)
6.3 North America Oncology Precision Medicine Market Size by Country
6.3.1 North America Oncology Precision Medicine Consumption Value by Country (2018-2029)
6.3.2 United States Oncology Precision Medicine Market Size and Forecast (2018-2029)
6.3.3 Canada Oncology Precision Medicine Market Size and Forecast (2018-2029)
6.3.4 Mexico Oncology Precision Medicine Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Oncology Precision Medicine Consumption Value by Type (2018-2029)
7.2 Europe Oncology Precision Medicine Consumption Value by Application (2018-2029)
7.3 Europe Oncology Precision Medicine Market Size by Country
7.3.1 Europe Oncology Precision Medicine Consumption Value by Country (2018-2029)
7.3.2 Germany Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.3 France Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.5 Russia Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.6 Italy Oncology Precision Medicine Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncology Precision Medicine Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oncology Precision Medicine Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Oncology Precision Medicine Consumption Value by Region (2018-2029)
8.3.2 China Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.3 Japan Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.4 South Korea Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.5 India Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.7 Australia Oncology Precision Medicine Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Oncology Precision Medicine Consumption Value by Type (2018-2029)
9.2 South America Oncology Precision Medicine Consumption Value by Application (2018-2029)
9.3 South America Oncology Precision Medicine Market Size by Country
9.3.1 South America Oncology Precision Medicine Consumption Value by Country (2018-2029)
9.3.2 Brazil Oncology Precision Medicine Market Size and Forecast (2018-2029)
9.3.3 Argentina Oncology Precision Medicine Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncology Precision Medicine Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oncology Precision Medicine Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Oncology Precision Medicine Consumption Value by Country (2018-2029)
10.3.2 Turkey Oncology Precision Medicine Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oncology Precision Medicine Market Size and Forecast (2018-2029)
10.3.4 UAE Oncology Precision Medicine Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Oncology Precision Medicine Market Drivers
11.2 Oncology Precision Medicine Market Restraints
11.3 Oncology Precision Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncology Precision Medicine Industry Chain
12.2 Oncology Precision Medicine Upstream Analysis
12.3 Oncology Precision Medicine Midstream Analysis
12.4 Oncology Precision Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Oncology Precision Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Precision Medicine by Type
1.3.1 Overview: Global Oncology Precision Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oncology Precision Medicine Consumption Value Market Share by Type in 2022
1.3.3 Applied Sciences
1.3.4 Precision Diagnostics
1.3.5 Digital Health and Information Technology
1.3.6 Precision Therapeutics
1.4 Global Oncology Precision Medicine Market by Application
1.4.1 Overview: Global Oncology Precision Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Lung Cancer
1.4.4 Colorectal Cancer
1.4.5 Prostate Cancer
1.4.6 Cervical Cancer
1.4.7 Other Cancer
1.5 Global Oncology Precision Medicine Market Size & Forecast
1.6 Global Oncology Precision Medicine Market Size and Forecast by Region
1.6.1 Global Oncology Precision Medicine Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oncology Precision Medicine Market Size by Region, (2018-2029)
1.6.3 North America Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.4 Europe Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.6 South America Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oncology Precision Medicine Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Precision Medicine Product and Solutions
2.1.4 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Oncology Precision Medicine Product and Solutions
2.2.4 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Almac
2.3.1 Almac Details
2.3.2 Almac Major Business
2.3.3 Almac Oncology Precision Medicine Product and Solutions
2.3.4 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Almac Recent Developments and Future Plans
2.4 ANGLE plc
2.4.1 ANGLE plc Details
2.4.2 ANGLE plc Major Business
2.4.3 ANGLE plc Oncology Precision Medicine Product and Solutions
2.4.4 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 ANGLE plc Recent Developments and Future Plans
2.5 Asuragen
2.5.1 Asuragen Details
2.5.2 Asuragen Major Business
2.5.3 Asuragen Oncology Precision Medicine Product and Solutions
2.5.4 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Asuragen Recent Developments and Future Plans
2.6 BGI Group
2.6.1 BGI Group Details
2.6.2 BGI Group Major Business
2.6.3 BGI Group Oncology Precision Medicine Product and Solutions
2.6.4 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BGI Group Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
2.7.4 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 BioM?rieux
2.8.1 BioM?rieux Details
2.8.2 BioM?rieux Major Business
2.8.3 BioM?rieux Oncology Precision Medicine Product and Solutions
2.8.4 BioM?rieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BioM?rieux Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
2.9.4 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Roche Holding AG
2.10.1 Roche Holding AG Details
2.10.2 Roche Holding AG Major Business
2.10.3 Roche Holding AG Oncology Precision Medicine Product and Solutions
2.10.4 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Roche Holding AG Recent Developments and Future Plans
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Oncology Precision Medicine Product and Solutions
2.11.4 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Gilead Sciences Recent Developments and Future Plans
2.12 Illumina
2.12.1 Illumina Details
2.12.2 Illumina Major Business
2.12.3 Illumina Oncology Precision Medicine Product and Solutions
2.12.4 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Illumina Recent Developments and Future Plans
2.13 Konica Minolta
2.13.1 Konica Minolta Details
2.13.2 Konica Minolta Major Business
2.13.3 Konica Minolta Oncology Precision Medicine Product and Solutions
2.13.4 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Konica Minolta Recent Developments and Future Plans
2.14 LabCorp
2.14.1 LabCorp Details
2.14.2 LabCorp Major Business
2.14.3 LabCorp Oncology Precision Medicine Product and Solutions
2.14.4 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 LabCorp Recent Developments and Future Plans
2.15 MDxHealth
2.15.1 MDxHealth Details
2.15.2 MDxHealth Major Business
2.15.3 MDxHealth Oncology Precision Medicine Product and Solutions
2.15.4 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 MDxHealth Recent Developments and Future Plans
2.16 Myriad Genetics
2.16.1 Myriad Genetics Details
2.16.2 Myriad Genetics Major Business
2.16.3 Myriad Genetics Oncology Precision Medicine Product and Solutions
2.16.4 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Myriad Genetics Recent Developments and Future Plans
2.17 Novartis
2.17.1 Novartis Details
2.17.2 Novartis Major Business
2.17.3 Novartis Oncology Precision Medicine Product and Solutions
2.17.4 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Novartis Recent Developments and Future Plans
2.18 OPKO Health
2.18.1 OPKO Health Details
2.18.2 OPKO Health Major Business
2.18.3 OPKO Health Oncology Precision Medicine Product and Solutions
2.18.4 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 OPKO Health Recent Developments and Future Plans
2.19 Pacific Biosciences
2.19.1 Pacific Biosciences Details
2.19.2 Pacific Biosciences Major Business
2.19.3 Pacific Biosciences Oncology Precision Medicine Product and Solutions
2.19.4 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Pacific Biosciences Recent Developments and Future Plans
2.20 Quest Diagnostics
2.20.1 Quest Diagnostics Details
2.20.2 Quest Diagnostics Major Business
2.20.3 Quest Diagnostics Oncology Precision Medicine Product and Solutions
2.20.4 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Quest Diagnostics Recent Developments and Future Plans
2.21 Qiagen
2.21.1 Qiagen Details
2.21.2 Qiagen Major Business
2.21.3 Qiagen Oncology Precision Medicine Product and Solutions
2.21.4 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Qiagen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncology Precision Medicine Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oncology Precision Medicine by Company Revenue
3.2.2 Top 3 Oncology Precision Medicine Players Market Share in 2022
3.2.3 Top 6 Oncology Precision Medicine Players Market Share in 2022
3.3 Oncology Precision Medicine Market: Overall Company Footprint Analysis
3.3.1 Oncology Precision Medicine Market: Region Footprint
3.3.2 Oncology Precision Medicine Market: Company Product Type Footprint
3.3.3 Oncology Precision Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncology Precision Medicine Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oncology Precision Medicine Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncology Precision Medicine Consumption Value Market Share by Application (2018-2023)
5.2 Global Oncology Precision Medicine Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Oncology Precision Medicine Consumption Value by Type (2018-2029)
6.2 North America Oncology Precision Medicine Consumption Value by Application (2018-2029)
6.3 North America Oncology Precision Medicine Market Size by Country
6.3.1 North America Oncology Precision Medicine Consumption Value by Country (2018-2029)
6.3.2 United States Oncology Precision Medicine Market Size and Forecast (2018-2029)
6.3.3 Canada Oncology Precision Medicine Market Size and Forecast (2018-2029)
6.3.4 Mexico Oncology Precision Medicine Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Oncology Precision Medicine Consumption Value by Type (2018-2029)
7.2 Europe Oncology Precision Medicine Consumption Value by Application (2018-2029)
7.3 Europe Oncology Precision Medicine Market Size by Country
7.3.1 Europe Oncology Precision Medicine Consumption Value by Country (2018-2029)
7.3.2 Germany Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.3 France Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.5 Russia Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.6 Italy Oncology Precision Medicine Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncology Precision Medicine Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oncology Precision Medicine Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Oncology Precision Medicine Consumption Value by Region (2018-2029)
8.3.2 China Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.3 Japan Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.4 South Korea Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.5 India Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.7 Australia Oncology Precision Medicine Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Oncology Precision Medicine Consumption Value by Type (2018-2029)
9.2 South America Oncology Precision Medicine Consumption Value by Application (2018-2029)
9.3 South America Oncology Precision Medicine Market Size by Country
9.3.1 South America Oncology Precision Medicine Consumption Value by Country (2018-2029)
9.3.2 Brazil Oncology Precision Medicine Market Size and Forecast (2018-2029)
9.3.3 Argentina Oncology Precision Medicine Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncology Precision Medicine Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oncology Precision Medicine Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Oncology Precision Medicine Consumption Value by Country (2018-2029)
10.3.2 Turkey Oncology Precision Medicine Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oncology Precision Medicine Market Size and Forecast (2018-2029)
10.3.4 UAE Oncology Precision Medicine Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Oncology Precision Medicine Market Drivers
11.2 Oncology Precision Medicine Market Restraints
11.3 Oncology Precision Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncology Precision Medicine Industry Chain
12.2 Oncology Precision Medicine Upstream Analysis
12.3 Oncology Precision Medicine Midstream Analysis
12.4 Oncology Precision Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncology Precision Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oncology Precision Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oncology Precision Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Oncology Precision Medicine Product and Solutions
Table 8. Abbott Laboratories Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Major Business
Table 12. Agilent Technologies Oncology Precision Medicine Product and Solutions
Table 13. Agilent Technologies Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Agilent Technologies Recent Developments and Future Plans
Table 15. Almac Company Information, Head Office, and Major Competitors
Table 16. Almac Major Business
Table 17. Almac Oncology Precision Medicine Product and Solutions
Table 18. Almac Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Almac Recent Developments and Future Plans
Table 20. ANGLE plc Company Information, Head Office, and Major Competitors
Table 21. ANGLE plc Major Business
Table 22. ANGLE plc Oncology Precision Medicine Product and Solutions
Table 23. ANGLE plc Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. ANGLE plc Recent Developments and Future Plans
Table 25. Asuragen Company Information, Head Office, and Major Competitors
Table 26. Asuragen Major Business
Table 27. Asuragen Oncology Precision Medicine Product and Solutions
Table 28. Asuragen Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Asuragen Recent Developments and Future Plans
Table 30. BGI Group Company Information, Head Office, and Major Competitors
Table 31. BGI Group Major Business
Table 32. BGI Group Oncology Precision Medicine Product and Solutions
Table 33. BGI Group Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BGI Group Recent Developments and Future Plans
Table 35. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 36. Bio-Rad Laboratories Major Business
Table 37. Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
Table 38. Bio-Rad Laboratories Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Bio-Rad Laboratories Recent Developments and Future Plans
Table 40. BioM?rieux Company Information, Head Office, and Major Competitors
Table 41. BioM?rieux Major Business
Table 42. BioM?rieux Oncology Precision Medicine Product and Solutions
Table 43. BioM?rieux Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. BioM?rieux Recent Developments and Future Plans
Table 45. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 46. Bristol Myers Squibb Major Business
Table 47. Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
Table 48. Bristol Myers Squibb Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol Myers Squibb Recent Developments and Future Plans
Table 50. Roche Holding AG Company Information, Head Office, and Major Competitors
Table 51. Roche Holding AG Major Business
Table 52. Roche Holding AG Oncology Precision Medicine Product and Solutions
Table 53. Roche Holding AG Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Roche Holding AG Recent Developments and Future Plans
Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 56. Gilead Sciences Major Business
Table 57. Gilead Sciences Oncology Precision Medicine Product and Solutions
Table 58. Gilead Sciences Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Gilead Sciences Recent Developments and Future Plans
Table 60. Illumina Company Information, Head Office, and Major Competitors
Table 61. Illumina Major Business
Table 62. Illumina Oncology Precision Medicine Product and Solutions
Table 63. Illumina Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Illumina Recent Developments and Future Plans
Table 65. Konica Minolta Company Information, Head Office, and Major Competitors
Table 66. Konica Minolta Major Business
Table 67. Konica Minolta Oncology Precision Medicine Product and Solutions
Table 68. Konica Minolta Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Konica Minolta Recent Developments and Future Plans
Table 70. LabCorp Company Information, Head Office, and Major Competitors
Table 71. LabCorp Major Business
Table 72. LabCorp Oncology Precision Medicine Product and Solutions
Table 73. LabCorp Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. LabCorp Recent Developments and Future Plans
Table 75. MDxHealth Company Information, Head Office, and Major Competitors
Table 76. MDxHealth Major Business
Table 77. MDxHealth Oncology Precision Medicine Product and Solutions
Table 78. MDxHealth Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. MDxHealth Recent Developments and Future Plans
Table 80. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 81. Myriad Genetics Major Business
Table 82. Myriad Genetics Oncology Precision Medicine Product and Solutions
Table 83. Myriad Genetics Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Myriad Genetics Recent Developments and Future Plans
Table 85. Novartis Company Information, Head Office, and Major Competitors
Table 86. Novartis Major Business
Table 87. Novartis Oncology Precision Medicine Product and Solutions
Table 88. Novartis Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments and Future Plans
Table 90. OPKO Health Company Information, Head Office, and Major Competitors
Table 91. OPKO Health Major Business
Table 92. OPKO Health Oncology Precision Medicine Product and Solutions
Table 93. OPKO Health Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. OPKO Health Recent Developments and Future Plans
Table 95. Pacific Biosciences Company Information, Head Office, and Major Competitors
Table 96. Pacific Biosciences Major Business
Table 97. Pacific Biosciences Oncology Precision Medicine Product and Solutions
Table 98. Pacific Biosciences Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Pacific Biosciences Recent Developments and Future Plans
Table 100. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 101. Quest Diagnostics Major Business
Table 102. Quest Diagnostics Oncology Precision Medicine Product and Solutions
Table 103. Quest Diagnostics Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Quest Diagnostics Recent Developments and Future Plans
Table 105. Qiagen Company Information, Head Office, and Major Competitors
Table 106. Qiagen Major Business
Table 107. Qiagen Oncology Precision Medicine Product and Solutions
Table 108. Qiagen Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Qiagen Recent Developments and Future Plans
Table 110. Global Oncology Precision Medicine Revenue (USD Million) by Players (2018-2023)
Table 111. Global Oncology Precision Medicine Revenue Share by Players (2018-2023)
Table 112. Breakdown of Oncology Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Oncology Precision Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Oncology Precision Medicine Players
Table 115. Oncology Precision Medicine Market: Company Product Type Footprint
Table 116. Oncology Precision Medicine Market: Company Product Application Footprint
Table 117. Oncology Precision Medicine New Market Entrants and Barriers to Market Entry
Table 118. Oncology Precision Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Oncology Precision Medicine Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Oncology Precision Medicine Consumption Value Share by Type (2018-2023)
Table 121. Global Oncology Precision Medicine Consumption Value Forecast by Type (2024-2029)
Table 122. Global Oncology Precision Medicine Consumption Value by Application (2018-2023)
Table 123. Global Oncology Precision Medicine Consumption Value Forecast by Application (2024-2029)
Table 124. North America Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Oncology Precision Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Oncology Precision Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Oncology Precision Medicine Raw Material
Table 155. Key Suppliers of Oncology Precision Medicine Raw Materials
Table 1. Global Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncology Precision Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oncology Precision Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oncology Precision Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Oncology Precision Medicine Product and Solutions
Table 8. Abbott Laboratories Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Major Business
Table 12. Agilent Technologies Oncology Precision Medicine Product and Solutions
Table 13. Agilent Technologies Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Agilent Technologies Recent Developments and Future Plans
Table 15. Almac Company Information, Head Office, and Major Competitors
Table 16. Almac Major Business
Table 17. Almac Oncology Precision Medicine Product and Solutions
Table 18. Almac Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Almac Recent Developments and Future Plans
Table 20. ANGLE plc Company Information, Head Office, and Major Competitors
Table 21. ANGLE plc Major Business
Table 22. ANGLE plc Oncology Precision Medicine Product and Solutions
Table 23. ANGLE plc Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. ANGLE plc Recent Developments and Future Plans
Table 25. Asuragen Company Information, Head Office, and Major Competitors
Table 26. Asuragen Major Business
Table 27. Asuragen Oncology Precision Medicine Product and Solutions
Table 28. Asuragen Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Asuragen Recent Developments and Future Plans
Table 30. BGI Group Company Information, Head Office, and Major Competitors
Table 31. BGI Group Major Business
Table 32. BGI Group Oncology Precision Medicine Product and Solutions
Table 33. BGI Group Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BGI Group Recent Developments and Future Plans
Table 35. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 36. Bio-Rad Laboratories Major Business
Table 37. Bio-Rad Laboratories Oncology Precision Medicine Product and Solutions
Table 38. Bio-Rad Laboratories Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Bio-Rad Laboratories Recent Developments and Future Plans
Table 40. BioM?rieux Company Information, Head Office, and Major Competitors
Table 41. BioM?rieux Major Business
Table 42. BioM?rieux Oncology Precision Medicine Product and Solutions
Table 43. BioM?rieux Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. BioM?rieux Recent Developments and Future Plans
Table 45. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 46. Bristol Myers Squibb Major Business
Table 47. Bristol Myers Squibb Oncology Precision Medicine Product and Solutions
Table 48. Bristol Myers Squibb Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol Myers Squibb Recent Developments and Future Plans
Table 50. Roche Holding AG Company Information, Head Office, and Major Competitors
Table 51. Roche Holding AG Major Business
Table 52. Roche Holding AG Oncology Precision Medicine Product and Solutions
Table 53. Roche Holding AG Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Roche Holding AG Recent Developments and Future Plans
Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 56. Gilead Sciences Major Business
Table 57. Gilead Sciences Oncology Precision Medicine Product and Solutions
Table 58. Gilead Sciences Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Gilead Sciences Recent Developments and Future Plans
Table 60. Illumina Company Information, Head Office, and Major Competitors
Table 61. Illumina Major Business
Table 62. Illumina Oncology Precision Medicine Product and Solutions
Table 63. Illumina Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Illumina Recent Developments and Future Plans
Table 65. Konica Minolta Company Information, Head Office, and Major Competitors
Table 66. Konica Minolta Major Business
Table 67. Konica Minolta Oncology Precision Medicine Product and Solutions
Table 68. Konica Minolta Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Konica Minolta Recent Developments and Future Plans
Table 70. LabCorp Company Information, Head Office, and Major Competitors
Table 71. LabCorp Major Business
Table 72. LabCorp Oncology Precision Medicine Product and Solutions
Table 73. LabCorp Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. LabCorp Recent Developments and Future Plans
Table 75. MDxHealth Company Information, Head Office, and Major Competitors
Table 76. MDxHealth Major Business
Table 77. MDxHealth Oncology Precision Medicine Product and Solutions
Table 78. MDxHealth Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. MDxHealth Recent Developments and Future Plans
Table 80. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 81. Myriad Genetics Major Business
Table 82. Myriad Genetics Oncology Precision Medicine Product and Solutions
Table 83. Myriad Genetics Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Myriad Genetics Recent Developments and Future Plans
Table 85. Novartis Company Information, Head Office, and Major Competitors
Table 86. Novartis Major Business
Table 87. Novartis Oncology Precision Medicine Product and Solutions
Table 88. Novartis Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments and Future Plans
Table 90. OPKO Health Company Information, Head Office, and Major Competitors
Table 91. OPKO Health Major Business
Table 92. OPKO Health Oncology Precision Medicine Product and Solutions
Table 93. OPKO Health Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. OPKO Health Recent Developments and Future Plans
Table 95. Pacific Biosciences Company Information, Head Office, and Major Competitors
Table 96. Pacific Biosciences Major Business
Table 97. Pacific Biosciences Oncology Precision Medicine Product and Solutions
Table 98. Pacific Biosciences Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Pacific Biosciences Recent Developments and Future Plans
Table 100. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 101. Quest Diagnostics Major Business
Table 102. Quest Diagnostics Oncology Precision Medicine Product and Solutions
Table 103. Quest Diagnostics Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Quest Diagnostics Recent Developments and Future Plans
Table 105. Qiagen Company Information, Head Office, and Major Competitors
Table 106. Qiagen Major Business
Table 107. Qiagen Oncology Precision Medicine Product and Solutions
Table 108. Qiagen Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Qiagen Recent Developments and Future Plans
Table 110. Global Oncology Precision Medicine Revenue (USD Million) by Players (2018-2023)
Table 111. Global Oncology Precision Medicine Revenue Share by Players (2018-2023)
Table 112. Breakdown of Oncology Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Oncology Precision Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Oncology Precision Medicine Players
Table 115. Oncology Precision Medicine Market: Company Product Type Footprint
Table 116. Oncology Precision Medicine Market: Company Product Application Footprint
Table 117. Oncology Precision Medicine New Market Entrants and Barriers to Market Entry
Table 118. Oncology Precision Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Oncology Precision Medicine Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Oncology Precision Medicine Consumption Value Share by Type (2018-2023)
Table 121. Global Oncology Precision Medicine Consumption Value Forecast by Type (2024-2029)
Table 122. Global Oncology Precision Medicine Consumption Value by Application (2018-2023)
Table 123. Global Oncology Precision Medicine Consumption Value Forecast by Application (2024-2029)
Table 124. North America Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Oncology Precision Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Oncology Precision Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Oncology Precision Medicine Raw Material
Table 155. Key Suppliers of Oncology Precision Medicine Raw Materials
LIST OF FIGURES
Figure 1. Oncology Precision Medicine Picture
Figure 2. Global Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncology Precision Medicine Consumption Value Market Share by Type in 2022
Figure 4. Applied Sciences
Figure 5. Precision Diagnostics
Figure 6. Digital Health and Information Technology
Figure 7. Precision Therapeutics
Figure 8. Global Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Oncology Precision Medicine Consumption Value Market Share by Application in 2022
Figure 10. Breast Cancer Picture
Figure 11. Lung Cancer Picture
Figure 12. Colorectal Cancer Picture
Figure 13. Prostate Cancer Picture
Figure 14. Cervical Cancer Picture
Figure 15. Other Cancer Picture
Figure 16. Global Oncology Precision Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Oncology Precision Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Oncology Precision Medicine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Oncology Precision Medicine Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Oncology Precision Medicine Consumption Value Market Share by Region in 2022
Figure 21. North America Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Oncology Precision Medicine Revenue Share by Players in 2022
Figure 27. Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Oncology Precision Medicine Market Share in 2022
Figure 29. Global Top 6 Players Oncology Precision Medicine Market Share in 2022
Figure 30. Global Oncology Precision Medicine Consumption Value Share by Type (2018-2023)
Figure 31. Global Oncology Precision Medicine Market Share Forecast by Type (2024-2029)
Figure 32. Global Oncology Precision Medicine Consumption Value Share by Application (2018-2023)
Figure 33. Global Oncology Precision Medicine Market Share Forecast by Application (2024-2029)
Figure 34. North America Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 44. France Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Oncology Precision Medicine Consumption Value Market Share by Region (2018-2029)
Figure 51. China Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 54. India Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 68. Oncology Precision Medicine Market Drivers
Figure 69. Oncology Precision Medicine Market Restraints
Figure 70. Oncology Precision Medicine Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Oncology Precision Medicine in 2022
Figure 73. Manufacturing Process Analysis of Oncology Precision Medicine
Figure 74. Oncology Precision Medicine Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Oncology Precision Medicine Picture
Figure 2. Global Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncology Precision Medicine Consumption Value Market Share by Type in 2022
Figure 4. Applied Sciences
Figure 5. Precision Diagnostics
Figure 6. Digital Health and Information Technology
Figure 7. Precision Therapeutics
Figure 8. Global Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Oncology Precision Medicine Consumption Value Market Share by Application in 2022
Figure 10. Breast Cancer Picture
Figure 11. Lung Cancer Picture
Figure 12. Colorectal Cancer Picture
Figure 13. Prostate Cancer Picture
Figure 14. Cervical Cancer Picture
Figure 15. Other Cancer Picture
Figure 16. Global Oncology Precision Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Oncology Precision Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Oncology Precision Medicine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Oncology Precision Medicine Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Oncology Precision Medicine Consumption Value Market Share by Region in 2022
Figure 21. North America Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Oncology Precision Medicine Revenue Share by Players in 2022
Figure 27. Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Oncology Precision Medicine Market Share in 2022
Figure 29. Global Top 6 Players Oncology Precision Medicine Market Share in 2022
Figure 30. Global Oncology Precision Medicine Consumption Value Share by Type (2018-2023)
Figure 31. Global Oncology Precision Medicine Market Share Forecast by Type (2024-2029)
Figure 32. Global Oncology Precision Medicine Consumption Value Share by Application (2018-2023)
Figure 33. Global Oncology Precision Medicine Market Share Forecast by Application (2024-2029)
Figure 34. North America Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 44. France Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Oncology Precision Medicine Consumption Value Market Share by Region (2018-2029)
Figure 51. China Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 54. India Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 68. Oncology Precision Medicine Market Drivers
Figure 69. Oncology Precision Medicine Market Restraints
Figure 70. Oncology Precision Medicine Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Oncology Precision Medicine in 2022
Figure 73. Manufacturing Process Analysis of Oncology Precision Medicine
Figure 74. Oncology Precision Medicine Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
